Literature DB >> 27471920

When Added to Opioid Agonist Treatment, Psychosocial Interventions do not Further Reduce the Use of Illicit Opioids: A Comment on Dugosh et al.

Robert P Schwartz1.   

Abstract

This commentary reviews the limitations of the recent literature review by that examined the role of psychosocial interventions with medication for opioid addiction treatment. The commonly held belief that opioid agonist treatment alone is inferior treatment to such treatment combined with 'psychosocial' treatment (which many will understand to mean counseling) is not supported by the research evidence and it results in limitations on the use of these effective medications.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27471920      PMCID: PMC4968580          DOI: 10.1097/ADM.0000000000000236

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  20 in total

1.  A randomized controlled trial of interim methadone maintenance: 10-Month follow-up.

Authors:  Robert P Schwartz; Jerome H Jaffe; David A Highfield; Jason M Callaman; Kevin E O'Grady
Journal:  Drug Alcohol Depend       Date:  2006-06-21       Impact factor: 4.492

2.  A randomized pilot clinical trial to evaluate the efficacy of Community Reinforcement and Family Training for Treatment Retention (CRAFT-T) for improving outcomes for patients completing opioid detoxification.

Authors:  Gregory S Brigham; Natasha Slesnick; Theresa M Winhusen; Daniel F Lewis; Xiamei Guo; Eugene Somoza
Journal:  Drug Alcohol Depend       Date:  2014-02-23       Impact factor: 4.492

3.  Impact of methadone with versus without drug abuse counseling on HIV risk: 4- and 12-month findings from a clinical trial.

Authors:  Sharon M Kelly; Robert P Schwartz; Kevin E Oʼgrady; Devang Gandhi; Jerome H Jaffe
Journal:  J Addict Med       Date:  2012-06       Impact factor: 3.702

4.  Interim methadone treatment compared to standard methadone treatment: 4-month findings.

Authors:  Robert P Schwartz; Sharon M Kelly; Kevin E O'Grady; Devang Gandhi; Jerome H Jaffe
Journal:  J Subst Abuse Treat       Date:  2011-02-24

5.  Effectiveness of intervention on improvement of drug use among methadone maintained adults.

Authors:  Adeline M Nyamathi; Karabi Nandy; Barbara Greengold; Mary Marfisee; Farinaz Khalilifard; Allan Cohen; Barbara Leake
Journal:  J Addict Dis       Date:  2011-01

6.  A randomized controlled trial of interim methadone maintenance.

Authors:  Robert P Schwartz; David A Highfield; Jerome H Jaffe; Joseph V Brady; Carol B Butler; Charles O Rouse; Jason M Callaman; Kevin E O'Grady; Robert J Battjes
Journal:  Arch Gen Psychiatry       Date:  2006-01

7.  Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings.

Authors:  Robert P Schwartz; Sharon M Kelly; Kevin E O'Grady; Devang Gandhi; Jerome H Jaffe
Journal:  Addiction       Date:  2012-02-11       Impact factor: 6.526

8.  Interim methadone treatment: impact on arrests.

Authors:  Robert P Schwartz; Jerome H Jaffe; Kevin E O'Grady; Timothy W Kinlock; Michael S Gordon; Sharon M Kelly; Monique E Wilson; Ashraf Ahmed
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492

9.  Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users.

Authors:  Kelly E Dunn; Anthony Defulio; Jeffrey J Everly; Wendy D Donlin; Will M Aklin; Paul A Nuzzo; Jeannie-Marie S Leoutsakos; Annie Umbricht; Michael Fingerhood; George E Bigelow; Kenneth Silverman
Journal:  Exp Clin Psychopharmacol       Date:  2012-12-03       Impact factor: 3.157

10.  A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification.

Authors:  Valerie A Gruber; Kevin L Delucchi; Anousheh Kielstein; Steven L Batki
Journal:  Drug Alcohol Depend       Date:  2008-04-01       Impact factor: 4.492

View more
  3 in total

1.  Adjunct interventions to standard medical management of buprenorphine in outpatient settings: A systematic review of the evidence.

Authors:  Jessica J Wyse; Benjamin J Morasco; Jacob Dougherty; Beau Edwards; Devan Kansagara; Adam J Gordon; P Todd Korthuis; Anaïs Tuepker; Stephan Lindner; Katherine Mackey; Beth Williams; Anders Herreid-O'Neill; Robin Paynter; Travis I Lovejoy
Journal:  Drug Alcohol Depend       Date:  2021-07-29       Impact factor: 4.852

2.  "It's way more than just writing a prescription": A qualitative study of preferences for integrated versus non-integrated treatment models among individuals with opioid use disorder.

Authors:  Elizabeth C Saunders; Sarah K Moore; Olivia Walsh; Stephen A Metcalf; Alan J Budney; Patricia Cavazos-Rehg; Emily Scherer; Lisa A Marsch
Journal:  Addict Sci Clin Pract       Date:  2021-01-27

3.  Readiness to Provide Medications for Addiction Treatment in HIV Clinics: A Multisite Mixed-Methods Formative Evaluation.

Authors:  E Jennifer Edelman; Geliang Gan; James Dziura; Denise Esserman; Kenneth L Morford; Elizabeth Porter; Philip A Chan; Deborah H Cornman; Benjamin J Oldfield; Jessica E Yager; Srinivas B Muvvala; David A Fiellin
Journal:  J Acquir Immune Defic Syndr       Date:  2021-07-01       Impact factor: 3.771

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.